M P Hill Selected Research

1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)

7/2001	Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.
9/2000	Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M P Hill Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 07/2001 - 06/2000
3	Dyskinesias (Dyskinesia) 01/2020 - 09/2000
1	AIDS-Related Complex (ARC) 03/2021
1	Shock 01/2021
1	Cognitive Dysfunction 01/2020
1	Parkinsonian Disorders (Parkinsonism) 07/2001
1	Movement Disorders (Movement Disorder) 07/2000

Drug/Important Bio-Agent (IBA)

4	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 06/2000
2	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 07/2001
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 07/2001 - 09/2000
1	DysprosiumIBA 03/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 07/2001
1	Apomorphine FDA Link 07/2001
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2001
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2001
1	IdazoxanIBA 07/2001
1	ifenprodilIBA 09/2000
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2000
1	EndocannabinoidsIBA 07/2000
1	CannabinoidsIBA 07/2000
1	Reserpine (Serpasil)FDA Link 07/2000
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2000
1	delta Opioid Receptors (delta Opioid Receptor)IBA 06/2000

Therapy/Procedure

3	Therapeutics 07/2001 - 06/2000
2	Lasers (Laser) 03/2021 - 01/2021